Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05802758
Other study ID # HUS/345/2023
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2023
Est. completion date December 31, 2029

Study information

Verified date July 2023
Source Helsinki University Central Hospital
Contact Nina Lindberg, PhD
Phone +358504270028
Email nina.lindberg@hus.fi
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to explore if individual CFT-based intervention with exposure training in virtual reality decreases conduct disorder symptoms and callous-unemoitonal traits , as well as increases subjective emotional welbeing among 15-to-20 year-old male prisoners and boys placed to state's residential schools. We will also study factors that may predict adherence to the intervention. These factors include mental well-being, motivation, and working alliance. In addition, we will evaluate the costs of the program.


Recruitment information / eligibility

Status Recruiting
Enrollment 144
Est. completion date December 31, 2029
Est. primary completion date September 30, 2028
Accepts healthy volunteers No
Gender Male
Age group 15 Years to 20 Years
Eligibility Inclusion Criteria: - Express conduct disorder psychopathology and psychopathic personality traits - Are placed to a prison or a state residential school for at least 9 months Exclusion Criteria: - Females - Non-Finninsh-speaking - Remaining in the institution facility less than 9 months - Intellectual dissability - Presence of psychotic symptoms - Autism - History of epilepsy - Currently participating another psychotherapeutic intervention

Study Design


Intervention

Behavioral:
Psychopathy.comp and training in virtual reality (VR)
Psychopathy.comp is a CFT-based manualized program of 20 sessions a 60 min, on a weekly basis. During the CFT-intervention, partipants try out their new skills in a tailored VR setting (x5)

Locations

Country Name City State
Finland Prison and Probation Service of Finland Helsinki
Finland State Residential Schools Helsinki

Sponsors (1)

Lead Sponsor Collaborator
Helsinki University Central Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary The self-reported change in Youth Pysychopathic traits Inventory- short version (YPI-S) and in the factors of it Measures both conduct prolems and psychopathic traits 5 months
Secondary Short Warwick-Edinburgh Wellbeing scale (SWEMWBS) measures general psychosocial well-being 5months
Secondary Difficulties in Emotion Regulating Scale-Short form (DERS-SF) measures emotion regulation style 5 months
Secondary WHO's quality of life questionnaire- Brief version (WHOQOL-BREF) measures quality of life 5 months
Secondary Self-Compassion Scale- Short Form (SCS-SF) measures self-compassion 5 months
Secondary Santa Clara Compassion Scale masures compassion against other people 5 months
Secondary Young Person's Clinical Outcomes in Routine Evaluation (YP-CORE) measures how the intervention is felt by the youngster 5 months
Secondary Situational intrinsic and extrinsic motivation scale (SIMS) measures younster's motivation to participate the intervention 5 months
Secondary Toronto Alexitymia Scale (TAS-20) measures aleksitymia 5 months
Secondary The Personal Feelings Questionnaire- brief version (PFQ-2 Brief) measures feelings of quilt 5 months
See also
  Status Clinical Trial Phase
Completed NCT03535805 - Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances N/A
Recruiting NCT05449002 - Digital Single Session Intervention for Youth Mental Health N/A
Withdrawn NCT02247986 - Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder Phase 1/Phase 2
Recruiting NCT04631042 - Developing Brain, Impulsivity and Compulsivity
Completed NCT02485587 - Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents N/A
Completed NCT00819429 - Supplements and Social Skills Intervention Study N/A
Completed NCT00626236 - Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems Phase 2
Completed NCT01085305 - The Effectiveness of Parent-Child Interaction Therapy (PCIT) N/A
Completed NCT00000385 - Long-Term Lithium Treatment for Aggressive Conduct Disorder Phase 3
Completed NCT00250354 - A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation Phase 3
Withdrawn NCT01443949 - Teenagers, Drug Addiction, and Reward and Impulse Control
Completed NCT04091633 - School Health Implementation Network: Eastern Mediterranean N/A
Completed NCT02563145 - Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents N/A
Completed NCT02766101 - Manville Moves: an Exercise Intervention for Behavioral Regulation Among Children With Behavioral Health Challenges N/A
Completed NCT00404911 - Multi-Family Group Therapy for Reducing Behavioral Difficulties in Youth N/A
Completed NCT00051727 - Prevention of School Dropout for Mexican American Adolescents Phase 2
Completed NCT02998073 - Investigating Psychosocial Intervention Treatment Response in Justice-Involved Youth With Conduct Disorder N/A
Completed NCT03292848 - Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders Phase 1
Recruiting NCT06373484 - Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents N/A
Recruiting NCT05637320 - Big Feelings: A Study on Children's Emotions in Therapy N/A